Chart's Smiling, Earnings Aren't Yet — The Day I Only Picked Up a Little JNJ

Today I only added Johnson & Johnson (JNJ) to the paper book. Nothing about its earnings, valuation, or risk really stands out — pretty middle-of-the-road stuff — but the price action and the overall mood around it have been noticeably good lately. So I'm riding the fact that it's moving rather than a clean reason why, and I'll be watching to see if that momentum actually turns into real fundamental improvement. BAC and AEM stayed on the watchlist — nothing pulled me in yet, so I'm just observing for now. Everything I'm already holding just stays put — no reason to sell, no reason to add more today.